Analyst consensus rating
IN8bio Analyst Rating: none
Direct answer
IN8bio's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked October 19, 2026.
Get free IN8bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.11
- Average price target
- $7.00
- High price target
- $10.00
- Low price target
- $5.00
- Low target gap
- +350.5%
- Target upside
- +530.6%
- High target gap
- +800.9%
- Target range width
- 450.5%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for IN8bio?
IN8bio has a verified none consensus. The same dataset has an average price target of $7.00.
How far are IN8bio's low and high targets from the recorded price?
The low target implies +350.5%, while the high target implies +800.9%.
How many analysts are included in IN8bio's consensus?
The verified consensus includes 3 analysts.
How is IN8bio's target upside or downside calculated?
The average target of $7.00 is divided by the recorded price of $1.11, then one is subtracted to produce +530.6%. This does not guarantee a future return.
When was IN8bio's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.